Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

2 Must-Have Pharma Stocks to Buy in August, 1 to Sell

The pharmaceutical industry is poised to thrive amid increasing global healthcare demand. Hence, two quality pharma stocks, Johnson & Johnson (JNJ) and Novartis AG (NVS), could be solid portfolio additions. However, avoiding fundamentally weak stock SNDL Inc. (SNDL) could be a wise choice. Read more.

StockNews.com

Which is the Better Value Stock for August: Catalyst Pharmaceuticals, Inc. (CPRX) vs. Teva Pharmaceutical Industries (TEVA)?

Fueled by steady demand, the pharmaceutical sector has shown resilience and expansion even in an uncertain economic environment. Amid this scenario, Catalyst Pharmaceuticals (CPRX) and Teva Pharmaceuticals (TEVA) are set to reap the rewards. However, which of the two is the better value stock for August? Read more to find…

StockNews.com

Are These Biotech Stocks a Buy or Sell for August: Bionano Genomics (BNGO) vs. Cidara Therapeutics (CDTX)?

Underpinned by undeniable growth trends of an aging population, breakthrough therapies, and the inelastic demand for healthcare products and medicines, the biotech industry is expected to perform well in the near term. Given this backdrop, let’s compare two biotech stocks, Bionano Genomics (BNGO) and Cidara Therapeutics (CDTX), to determine if…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Johnson & Johnson (JNJ) a Must-Buy Stability Stock?

Thanks to the company’s solid first-quarter performance and growing pharmaceutical demand, Johnson & Johnson’s (JNJ) long-term prospects look bright. However, could the company ensure stability for investors amid the current market volatility? Keep reading….

StockNews.com

Dangerous diseases found in illegal California medical lab with nearly 1,000 bioengineered mice

Police are still investigating the lab’s origins

The Independent UK

Biotech company settles lawsuit for profiting off of woman’s cloned cells for seven decades

Henrietta Lacks’ unique ‘Hela’ cells played a crucial role in the development of Covid-19 vaccines and treatments for HIV, leukemia and cancer

The Independent UK

Brain fog and other long COVID symptoms are the focus of new small treatment studies

The National Institutes of Health is starting some studies to test possible treatments for long COVID

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Centene Corporation’s Profits Heavily In Healthcare On Their Second Quarter Profits

The company reported a quarterly revenue of $33.71 billion and a net profit of $1.06 billion in their latest earnings release

Zenger

What's a fair price for a prescription drug? Medicare's about to weigh in

Medicare soon will start something it hasn't done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.

WEKU

Top 3 Pharma Stocks You Can’t Miss out On

The ever-transforming pharmaceuticals sector is ready to seize the opportunity to address the growing demand for healthcare across the globe. Therefore, adding these three quality pharma stocks, Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), and Dr. Reddy's Laboratories (RDY), to your portfolio could prove to be beneficial. Read…

StockNews.com

Court says OxyContin maker's bankruptcy and protections for Sackler family members can move ahead

OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family who own the company to avoid civil lawsuits over the opioid crisis, a court has ruled

The Independent UK

Is AbbVie (ABBV) a Better Stock to Buy Than Pfizer (PFE)?

Due to the emergence of new technologies and the introduction of generic medicines, the pharma industry seems well-positioned to witness growth. While pharma stocks should benefit from the industry tailwinds, let us analyze whether AbbVie (ABBV) is a better buy than Pfizer (PFE).

StockNews.com

Nigel Farage says NatWest management ‘should go’ after CEO Rose admits discussing his bank account with BBC – as it happened

Dame Alison Rose admitted to serious error in discussing Nigel Farage’s relationship with Coutts with a BBC journalist.

The Guardian - UK

Explained | Will generic supply of bedaquiline be accessible?

J&J's patent on bedaquiline expired, allowing generic manufacturers to supply the drug. J&J has filed secondary patents. Prices are expected to reduce 3-6x, but some countries are excluded from the deal, raising concerns.

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says

A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas

Chicago Tribune

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.

StockNews.com

Are These 3 Medical Stocks a Safe Investment?

The future of the medical devices and equipment industry looks buoyant, given rising chronic conditions and the adoption of advanced technology. Given this backdrop, would it be prudent for investors to buy medical stocks, Terumo Corporation (TRUMY), Haemonetics Corp. (HAE), and MiMedx Group (MDXG)? Read more to find out….

The Independent UK

Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need

U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma

The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma

The Hindu

Medical device industry asks Health Ministry to reconsider new regulatory Bill

The new Bill, to regulate drugs and medical devices, was formulated without input from major stakeholders, device manufacturers claim. They also want a separate law for regulation of their industry.

The Hindu

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India

MSF reiterated its call for Johnson & Johnson to publicly announce that it will not enforce any ‘secondary’ patents for bedaquiline in any country with a high burden of TB, as J&J’s 20-year primary patent on bedaquiline expired on July 18.

Tribune News Service

FDA issues recall for 348,616 Medtronic defibrillators over potential cardiac arrest risk

The U.S. Food and Drug Administration issued its most serious type of recall for 348,616 Medtronic defibrillators, saying they are at risk for delivering "a reduced-energy shock or not shock at all," which could lead to cardiac arrest for a patient.

Tribune News Service

What you need to know about the drug price fight in those TV ads

In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it’s not always clear who’s sponsoring the ads or why.

The Guardian - UK

Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’

The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution

The Guardian - UK

Cheaper TB drugs for millions after global deal on patent rights agreed

Johnson & Johnson allows generic bedaquiline in 44 countries – but concerns remain about ‘stopgap’ solution

1 … 46 47 48 49

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

2,618 stories

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.